Drugs / estrodiol
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT06144814 Comparator | Apr → Sep 2023 | postmenopausal atrophic vaginitis | Koru Health Groups | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | estrodiol | “Group I received 25 µg vaginal estrodiol (Vagifem®).” NCT06144814 ↗ |
| Known as | Vagifem | “Group I received 25 µg vaginal estrodiol (Vagifem®).” NCT06144814 ↗ |